Characterizing PDK4 and PKC-Theta in Pancreatic Cancer and Cachexia

Date
2025-11
Language
American English
Embargo Lift Date
Department
Committee Chair
Degree
Ph.D.
Degree Year
2025
Department
Biochemistry & Molecular Biology
Grantor
Indiana University
Journal Title
Journal ISSN
Volume Title
Found At
Can't use the file because of accessibility barriers? Contact us with the title of the item, permanent link, and specifics of your accommodation need.
Abstract

Cachexia is an involuntary wasting syndrome that cannot be reversed by nutritional support. It affects most patients with pancreatic ductal adenocarcinoma (PDAC) and is believed to cause 20% of cancer-associated deaths. Cachectic patients exhibit both metabolic abnormalities and systemic inflammation. Pyruvate Dehydrogenase Kinase 4 (PDK4) is upregulated in the skeletal muscles of many cancer cachexia models and has been shown to drive muscle wasting in some conditions. We show that despite being upregulated in an orthotopic mouse model of PDAC cachexia, whole-body deletion of PDK4 did not prevent the decline in muscle function or the overall wasting. Expression of the other members of the PDK family did not change, ruling out a compensatory mechanism. Deletion of PDK4 did not affect the dysregulated expression of metabolic and catabolic genes in PDAC cachexia. Analysis of publicly available muscle-expression datasets from cachectic cancer patients further revealed that PDK4 is not upregulated in patients' skeletal muscles. Protein Kinase C theta (PKCθ) is a lipid-sensitive kinase expressed in skeletal muscle where it regulates insulin signaling. It is also expressed in T cells, and its deletion alleviates inflammation in several inflammatory conditions. We found that PKCθ expression increases in skeletal muscle but decreases in the spleen in PDAC cachexia as the disease progresses. To delineate its role in PDAC cachexia, we generated mouse models with skeletal muscle-specific, T cell-specific, and whole-body deletion of PKCθ. Deletion of PKCθ did not substantially affect body weight or composition at baseline in any of these models. It also did not affect the wasting or tumor burden in PDAC cachexia. PKCθ-deficient T cells maintained their ability to infiltrate PDAC tumors. Overall, our work shows that despite being upregulated, PDK4 is not required for PDAC cachexia, and PKCθ is dispensable for both wasting and inflammation in this context.

Description
IUI
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Source
Alternative Title
Type
Thesis
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Full Text Available at
This item is under embargo {{howLong}}